Consumer Staples · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Cellyan Biotechnology Co., Ltd (HKPD) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. HKPD is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $20.3m in revenue and is scored on the micro-cap board instead. HKPD trades on the Nasdaq exchange and files with the SEC under CIK 2007702. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HKPD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cellyan Biotechnology Co., Ltd directly from SEC EDGAR.
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $20.3M | — | — |
| FY 2024 | 20-F | $16.7M | — | — |
| FY 2023 | 20-F | $12.6M | — | — |
13F Pro Quality Score
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $20.3M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Financial metrics will appear once SEC EDGAR data is ingested for this company.